|The Company was incorporated on 17.6.1988 as a private
limited company under the name Arvind Remedies Pvt. Ltd.
Subsequently it was converted into a public limited company
by passing a special resolution 7th April 1995 and obtaining
a fresh certificate of incorporation on 18th May 1995 and
consequently the name change.
The Registered Office and the factory of the company
measuring 4,400 sq.ft. are located at 25/9 Nelson Manickam
Road, Mehta Nagar, Madras 600 029. For the above purpose
the company has entered into a five year lease agreement
with Mr. O.M. Shahul Ameed and Syed Ahmed. The monthly lease
rent is Rs.15,400 and an advance of Rs.75,000 was paid for
the same. The company has a depot measuring 2500 sq.ft. at
23/1 Railway Colony, II Street, Madras - 29 and the
premises has been taken on lease from Deluxe Tools &
Moulders. The monthly lease rent is Rs.7,500 and an advance
of Rs.30,000 was paid for the same.
The company is presently having production facilities for
manufacturing tablets and capsules. This is located at
Nelson Manickam Road, Aminjikarai, Madras.
The existing manufacturing unit possesses a valid
manufacturing licence and is approved by the Drugs
Directorate far Good Manufacturing Practice (G.M.P.)
Certificate as per the norms of the World Health
The Company started its operations with 6 products for
supply to Institutions like Directorate of Medical Service
of Tamil Nadu, Directorate of Preventive and Primary Health
Centre, Tamil Nadu, Government of Medical Stores, Hyderabad,
& other Government Institutions in Kerala and Karnataka.
It has since then expanded its operations and today
manufactures over 80 products in various segments like
ethical, generic and exports besides Institutions in the
There has been no labour problems or closures in the past.
-Arvind Remedies has offered a safety net for its prospective investors.
2001 - Right issue of 14,86,000 No. of Equity Shares of Rs 10/- each at a premium
of Rs 90/- per share in the ratio of one equity share for every four equity shares
held aggregating Rs 14.86 crores.
-Successfully launched two herbal products recently throughout India viz. Pankare and Sorexil
-Board approved the equity preferential allotment of USD 10 million to Citiconsult Emerging Markets, UK.
-Board approves FIIs to invest upto 24% in the equity of the company